Ontario Genomics Opens Funding Application for Genomics Technologies
A new round of Genome Canada’s Genomic Applications Partnership Program (GAPP) funding is now available for research collaborations on developing genomics-derived technologies.
Global Affairs Canada and Trade Commissioner Service Accepting Applications for Life Sciences Program in San Francisco
Canadian Technology Accelerator (CTA) San Francisco – Life Sciences is an intensive program run by the Trade Commissioner Service (TCS) team in San Francisco. It offers Canadian companies the opportunity to expand their business in a global hub for the life sciences sector. The program is accepting applications for the winter 2018 cohort, which will run November 2018 – February 2019.
Synaptive Medical's Modus V™ Acquired By World Renowned Academic Medical Center
Synaptive Medical announced that Duke University Medical Center has acquired its connected neurosurgery system.
OBIO Hosts Dr. Jonathan Shieh, Taipei Economic and Cultural Office and Government of Ontario officials
Last week, OBIO hosted a day of meetings with Dr. Jonathan Shieh, Executive Director, Science and Technology Division of the Taipei Economic and Cultural Office which brought Dr. Shieh together with officials from the Ontario government, Ministry of Economic Development, Job Creation and Trade, as well as high-potential Ontario health science companies.
Are You Looking For Help with Market Research, Marketing or Financing?
OBIO H2BB is now offering top graduate-level, business-trained students and recent graduates, who will expand your business, marketing and/or finance strategies through market research, investor targeting, or conference preparation.
Biotechnology Focus Magazine Launches Survey
Biotechnology Focus magazine is conducting a survey to gauge Canada’s innovation culture. In support of Global Biotech Week (Sept 24-30), add your voice to the Innovation Report by taking this quick survey by July 27th.
Commercializing Healthcare Solutions in the U.S., July 26, 2018
VentureLAB brings you a collaborative workshop offering real-world, practical tools, frameworks and tips for commercializing digital healthcare solutions in the U.S. market.
Recapping 'How Do VCs Value Health Science Companies? From Valuation to Deal Structure'
On June 25th, OBIO organized a workshop with two industry leaders and provided a VC perspective on how they valuate start-up companies and on how this is translated into a deal structure, featuring presentations by Richard Meadows (General Partner, BioInnovation Capital Fund & OBIO Board Director) and Andy Haigh (COO, Adapsyn Bioscience).
Accel-Rx Portfolio Companies Secure $40 Million Follow-On Funding
KisoJi, SoundBite and Zucara, three of Accel-Rx’s portfolio companies, together raised a total of $40 million CDN in follow-on funding to advance the development and commercialization of their technologies.
New Guide Addresses Procurement Myths to Promote Innovation Adoption in Ontario
The Council of Academic Hospitals of Ontario (CAHO) has published a quick reference guide to help tackle procurement myths to pull innovation into the health system faster.
Investor Spotlights: Amgen and AmorChem - JLABS Toronto
JLABS Meet with.. Series helps build partnerships with Amgen and AmorChem. Amgen is seeking for opportunities in relation to their capabilities in oncology, bone health, nephrology, metabolic disorders, neuroscience, inflammation, cardiovascular, discovery research and technology. AmorChem involves financing research-stage projects for them to reach pre-clinical proof-of-concept in a semi-virtual mode.
Antibe Therapeutics Releases Secondary Endpoint Data for Lead Drug
Toronto’s Antibe Therapeutics released positive secondary endpoint data, conducted in their 244 patients, from the recent Phase 2B Gastrointestinal safety study for its lead drug, ATB-346. These results are consistent with the primary endpoint data, previously released on March 20, 2018.
Reviewing 'Formulating a Non-Dilutive Fundraising Strategy', Part 2 of OBIO's 'Building Your Early-Stage Strategy Toolbox' Event
On the evening of Tuesday, June 26th, David Cayea (COO, PlantForm Corporation) shared how PlantForm had developed a strategy for securing non-dilutive funding, through which they had raised over $6.5M in funding, via grants and research contracts alone.
Government of Canada Announces Stream 4 of the Strategic Innovation Fund
The Government of Canada has announced Stream 4 of the Strategic Innovation Fund and that Statements of Interest will be accepted until August 31, 2018.
Ontario Trade Mission to AdvaMed 2018: The MedTech Conference, September 24-26, 2018
Ontario's Ministry of International Trade is organizing a Trade Mission to AdvaMed 2018: The MedTech Conference, September 24-26, 2018, Pennsylvania Convention Center. This Trade Mission will be able to accommodate a maximum of eight Ontario companies.
Ontario 2018 Rehabilitation & Assistive Device Mission to China
Ontario companies with capabilities in rehabilitation or assistive technology and device that can help China better take care of its disabled and aging population are warmly invited to B2B meetings, site visits and briefing, seminars/forum, and exhibitions of the Canada Pavilion at the 2018 China International Care & Rehabilitation Expo (CRE) in Beijing.
Reviewing OBIO's Building Your Early-Stage Strategy Toolbox
On June 26th, OBIO hosted Building Your Early-Stage Strategy Toolbox featuring sessions on formulating a non-dilutive funding strategy, early-stage business strategies, and preparing investor materials.
Perimeter Medical Appoints New CEO
Perimeter is pleased to announce the appointment of Charles S. Carignan as the New CEO, who has an extensive experience in developing and commercializing innovative OCT based tissue imaging solutions.
Engaging with the FDA: An Insider's Perspective - Reviewing Dr. Yuan's Six Considerations
On June 14th, OBIO hosted Dr. Yuan Fang (VP Regulatory Affairs, Quality and Manufacturing; Focal Healthcare Inc.) who spoke about his perspective on the recent changes at the U.S. Food and Drug Administration (FDA).
Seeking Digital Health Companies for Springboard Health Hub
Springboard is recruiting women-led digital health companies to join their 2018 Health Innovation Hub cohort to help those seeking growth funding accelerate through an inflection point of growth.